CURB-65评分对社区获得性肺炎住院患者重症监护干预的预测效能
本研究为单中心回顾性电子健康记录分析,纳入2010至2014年急诊以肺炎为主要诊断住院的成年患者,排除恶性肿瘤、结核、支气管扩张、HIV或14天内再入院者,共2322例。评估CURB-65预测重症监护干预(血管加压药、大量静脉补液、侵入性导管、辅助通气、胰岛素输注或肾脏替代治疗)及院内死亡的表现。CURB-65 0-1分者6.4%接受重症干预、0.6%死亡;2分者15.4%接受干预、5.7%死亡;≥3分者42.1%接受干预、12.8%死亡。CURB-65预测重症干预和死亡的AUC分别为0.73和0.77,≥2分预测重症干预的敏感性为78.4%,预测死亡为92.8%。作者认为CURB-65≤2分患者常接受重症干预且该评分对重症干预敏感性较低,临床用以指导分流时应谨慎。
要点
- CURB-65≤2分的社区获得性肺炎患者中,181例(15.6%)在急诊分诊后48小时内收入ICU,74例(6.4%)接受重症监护干预。
- CURB-65≥3分患者中226例(67.0%)收入ICU、142例(42.1%)接受重症干预、43例(12.8%)死亡。
- CURB-65预测重症监护干预的AUC为0.73,预测院内死亡的AUC为0.77。
- CURB-65≥2分预测重症监护干预的敏感性为78.4%,预测死亡的敏感性为92.8%。
- 作者认为CURB-65对重症干预敏感性相对较低,临床用于指导分流决策时应谨慎。
适用人群与场景
- 2010至2014年单中心急诊就诊、以肺炎为主要诊断住院的成年患者。
- 排除有恶性肿瘤、结核、支气管扩张、HIV病史或14天内再入院者。
研究设计与关键结果
- 研究类型为单中心回顾性电子健康记录分析,共纳入2322例急诊住院社区获得性肺炎患者。
- 630例(27.1%)在急诊分诊后48小时内收入ICU,343例(14.8%)接受重症监护干预。
- CURB-65 0-1分患者中181例(15.6%)收入ICU、74例(6.4%)接受重症干预、7例(0.6%)死亡。
- CURB-65 2分患者中223例(27.0%)收入ICU、127例(15.4%)接受重症干预、47例(5.7%)死亡。
- CURB-65≥3分患者中226例(67.0%)收入ICU、142例(42.1%)接受重症干预、43例(12.8%)死亡。
- CURB-65预测重症监护干预的AUC为0.73,预测院内死亡的AUC为0.77。
- CURB-65≥2分预测重症监护干预的敏感性为78.4%,预测死亡的敏感性为92.8%。
证据类型、等级与局限
- 证据类型:单中心回顾性队列分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,鉴于CURB-65≤2分患者常被收入ICU并接受重症干预、且CURB-65对重症干预敏感性相对较低,临床医生使用CURB-65指导分流时应谨慎。
- 作者提出,未来基于急诊的临床预测规则可能受益于对近端结局的校准。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: Confusion, uremia, elevated respiratory rate, hypotension, and aged 65 years or older (CURB-65) is a clinical prediction rule intended to stratify patients with pneumonia by expected mortality. We assess the predictive performance of CURB-65 for the proximal endpoint of receipt of critical care intervention in emergency department (ED) patients admitted with community-acquired pneumonia.
METHODS: We performed a retrospective analysis of electronic health records from a single tertiary center for ED patients admitted as inpatients with a primary diagnosis of pneumonia from 2010 to 2014. Patients with a history of malignancy, tuberculosis, bronchiectasis, HIV, or readmission within 14 days were excluded. We assessed the predictive accuracy of CURB-65 for receipt of critical care interventions (ie, vasopressors, large-volume intravenous fluids, invasive catheters, assisted ventilation, insulin infusions, or renal replacement therapy) and inhospital mortality. Logistic regression was performed to assess the increase in odds of critical care intervention or inhospital mortality by increasing CURB-65 score.
RESULTS: There were 2,322 patients admitted with community-acquired pneumonia in the study cohort; 630 (27.1%) were admitted to the ICU within 48 hours of ED triage and 343 (14.8%) received a critical care intervention. Of patients with a CURB-65 score of 0 to 1, 181 (15.6%) were admitted to the ICU, 74 (6.4%) received a critical care intervention, and 7 (0.6%) died. Of patients with a CURB-65 score of 2, 223 (27.0%) were admitted to the ICU, 127 (15.4%) received a critical care intervention, and 47 (5.7%) died. Among patients with CURB-65 score greater than or equal to 3, 226 (67.0%) were admitted to the ICU, 142 (42.1%) received a critical care intervention, and 43 (12.8%) died. The areas under the receiver operating characteristic for CURB-65 as a predictor of critical care intervention and mortality were 0.73 and 0.77, whereas sensitivity of CURB-65 score greater than or equal to 2 in predicting critical care intervention was 78.4%; for mortality, 92.8%.
CONCLUSION: Patients with CURB-65 score less than or equal to 2 were often admitted to the ICU and received critical care interventions. Given this finding and the relatively low sensitivity of CURB-65 for critical care intervention, clinicians should exercise caution when using CURB-65 to guide disposition. Future ED-based clinical prediction rules may benefit from calibration to proximal endpoints.
参考来源
- Ilg A, Moskowitz A, Konanki V, et al. Performance of the CURB-65 Score in Predicting Critical Care Interventions in Patients Admitted With Community-Acquired Pneumonia. Ann Emerg Med. 2018. PMID: 30078659. doi:10.1016/j.annemergmed.2018.06.017
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。